Tales Of Optimism Inside Olivetti's Brave New Labs

IVREA. ITALY—In a cluttered laboratory on the first floor of a new building in the northern Italy town of Ivrea, three Olivetti employees huddle together at a bench. One scribbles with a pencil on a small electronic slate connected to a computer, while the others peer intently at the screen, where the image entered on the slate appears. Their goal to shoehorn a telephone, a scanner (for entering documents into the computer), a printer, and the electronic “paper” into a box li

Written byAngola Bono
| 6 min read

Register for free to listen to this article
Listen with Speechify
0:00
6:00
Share

IVREA. ITALY—In a cluttered laboratory on the first floor of a new building in the northern Italy town of Ivrea, three Olivetti employees huddle together at a bench. One scribbles with a pencil on a small electronic slate connected to a computer, while the others peer intently at the screen, where the image entered on the slate appears.

Their goal to shoehorn a telephone, a scanner (for entering documents into the computer), a printer, and the electronic “paper” into a box little more than the size of a small book. If Olivetti has its way, this little box will be the hub of the office of the future— and the key to turning around the company’s declining fortunes.

Two of those in the group at the bench are staff scientists. But the third is 40-year-old Hermann Hauser, Ing.C. Olivetti & C. SpA’s chief scientific officer, who often slips into one ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Published In

Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

Parse Logo

Parse Biosciences and Graph Therapeutics Partner to Build Large Functional Immune Perturbation Atlas